Shannon Cartier

508 total citations
13 papers, 338 citations indexed

About

Shannon Cartier is a scholar working on Infectious Diseases, Epidemiology and Hematology. According to data from OpenAlex, Shannon Cartier has authored 13 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Infectious Diseases, 2 papers in Epidemiology and 2 papers in Hematology. Recurrent topics in Shannon Cartier's work include Multiple Myeloma Research and Treatments (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Shannon Cartier is often cited by papers focused on Multiple Myeloma Research and Treatments (2 papers), Viral gastroenteritis research and epidemiology (1 paper) and SARS-CoV-2 and COVID-19 Research (1 paper). Shannon Cartier collaborates with scholars based in United States, Canada and Switzerland. Shannon Cartier's co-authors include Virginia M. Rosen, Victoria Zarotsky, Larry Radican, Kristy Iglay, Swapnil Rajpathak, Kaan Tunceli, Moisés A. Calderón, Harold S. Nelson, Felicia Allen‐Ramey and M. Karen Campbell and has published in prestigious journals such as Blood, Schizophrenia Research and Clinical Therapeutics.

In The Last Decade

Shannon Cartier

11 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shannon Cartier United States 8 89 74 71 68 52 13 338
Takehito Fukui Japan 11 22 0.2× 36 0.5× 27 0.4× 3 0.0× 30 0.6× 24 342
Megan C. Saucke United States 15 284 3.2× 8 0.1× 9 0.1× 14 0.2× 16 0.3× 36 534
Federico Bellini Italy 2 15 0.2× 67 0.9× 15 0.2× 3 0.0× 18 0.3× 4 211
E Eyles New Zealand 8 33 0.4× 159 2.1× 48 0.7× 21 0.4× 12 381
C. Robin Clifford United States 8 160 1.8× 11 0.1× 4 0.1× 2 0.0× 44 0.8× 12 346
T. Svahn United States 6 20 0.2× 304 4.1× 24 0.3× 10 0.1× 33 0.6× 8 510
Vivian Chia‐Rong Hsieh Taiwan 10 30 0.3× 69 0.9× 45 0.6× 1 0.0× 87 1.7× 36 354
Firas Farisi Alkaff Indonesia 10 29 0.3× 20 0.3× 6 0.1× 8 0.1× 23 0.4× 67 245
F Lombardo United States 9 42 0.5× 27 0.4× 13 0.2× 54 1.0× 14 379
Afif Mufarrij Lebanon 11 10 0.1× 29 0.4× 21 0.3× 2 0.0× 29 0.6× 29 283

Countries citing papers authored by Shannon Cartier

Since Specialization
Citations

This map shows the geographic impact of Shannon Cartier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Cartier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Cartier more than expected).

Fields of papers citing papers by Shannon Cartier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Cartier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Cartier. The network helps show where Shannon Cartier may publish in the future.

Co-authorship network of co-authors of Shannon Cartier

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Cartier. A scholar is included among the top collaborators of Shannon Cartier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Cartier. Shannon Cartier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Kohli, Michele, et al.. (2026). Modeling the cost-effectiveness of the next-generation COVID-19 mRNA-1283 vaccine in the United States. Journal of Medical Economics. 29(1). 574–593.
2.
Kohli, Michele, et al.. (2025). The potential impact of the next-generation COVID-19 mRNA-1283 vaccine in Canada. Journal of Medical Economics. 28(1). 1440–1450. 2 indexed citations
3.
4.
5.
6.
O’Hanlon, Claire E, Anju Parthan, Shannon Cartier, et al.. (2017). A Model for Assessing the Clinical and Economic Benefits of Bone-forming Agents for Reducing Fractures in Postmenopausal Women at High, Near-term Risk of Osteoporotic Fracture. Clinical Therapeutics. 39(7). 1276–1290. 13 indexed citations
7.
Cartier, Shannon, Bin Zhang, Virginia M. Rosen, et al.. (2015). Relationship between Treatment Effects on Progression-Free Survival and Overall Survival in Multiple Myeloma: A Systematic Review and Meta-Analysis of Published Clinical Trial Data. Oncology Research and Treatment. 38(3). 88–94. 24 indexed citations
8.
Iglay, Kristy, Shannon Cartier, Virginia M. Rosen, et al.. (2015). Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Current Medical Research and Opinion. 31(7). 1283–1296. 118 indexed citations
9.
Nelson, Harold S., et al.. (2014). Network Meta-analysis Shows Commercialized Subcutaneous and Sublingual Grass Products Have Comparable Efficacy. The Journal of Allergy and Clinical Immunology In Practice. 3(2). 256–266.e3. 73 indexed citations
10.
Campbell, M. Karen, et al.. (2012). Determinants of Small for Gestational Age Birth at Term. Paediatric and Perinatal Epidemiology. 26(6). 525–533. 67 indexed citations
11.
Zhang, Bin, Shannon Cartier, Virginia M. Rosen, et al.. (2012). Investigation of the Association Between Treatment Effects On Progression Free Survival and Overall Survival in Multiple Myeloma Using Data From Published Literature. Blood. 120(21). 4241–4241. 1 indexed citations
12.
Reboli, Annette C., Coleman Rotstein, Daniel H. Kett, et al.. (2011). Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis. PharmacoEconomics. 29(8). 705–717. 20 indexed citations
13.
Srihari, Vinod H., Scott W. Woods, Brooks Walsh, et al.. (2006). 0205 SPECIALIZED TREATMENT EARLY IN PSYCHOSIS (STEP): A PRAGMATIC RANDOMIZED CONTROLLED TRIAL IN THE US PUBLIC SECTOR. Schizophrenia Research. 86. S165–S165. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takehito Fukui Breakdown of academic impact, for papers by Megan C. Saucke Breakdown of academic impact, for papers by Federico Bellini Breakdown of academic impact, for papers by E Eyles Breakdown of academic impact, for papers by C. Robin Clifford Breakdown of academic impact, for papers by T. Svahn Breakdown of academic impact, for papers by Vivian Chia‐Rong Hsieh Breakdown of academic impact, for papers by Firas Farisi Alkaff Breakdown of academic impact, for papers by F Lombardo Breakdown of academic impact, for papers by Afif Mufarrij
Rankless by CCL
2026